This content is Free Access.
NeuroStar TMSデバイス：うつ病の治療薬としてFDA承認されたプロトコルを実施
39,024 Views
•
10:29 min
•
November 12, 2010
DOI:
Summary
Automatically generated
この記事では、我々はNeuronetics NeuroStar TMSデバイスを使用してFDA承認されたうつ病の治療プロトコルに関連する方法論と考慮事項を検討する。
Explore More Videos
NeuroStar TMS DeviceFDA Approved ProtocolTreatment Of DepressionNeuroStar Transcranial Magnetic Stimulation (TMS) SystemClass II Medical DevicePulsed Magnetic FieldsElectrical CurrentsCortexPhysiological ChangesFunctional Brain ChangesO’Reardon Et Al.Industry-sponsored Clinical TrialMajor DepressionAntidepressant Treatment TrialActive TMSSham TMSLeft Dorsolateral Prefrontal Cortex (DLPFC)Medication-free PatientsMontgomery-Asberg Depression Scale (MADRS)Hamilton Depression Rating Scale (HAMD)FDA Approval
Read Article
Cite this Article
Horvath, J. C., Mathews, J., Demitrack, M. A., Pascual-Leone, A. The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression. J. Vis. Exp. (45), e2345, doi:10.3791/2345 (2010).
Copy